Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. slid 4.3% to $53.86 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,348.35 and Dow Jones Industrial Average falling 0.9% to 53,885.10.

This was the stock's second consecutive day of losses.

Moderna Inc. closed 37.1% short of its 52-week high of $85.60, which the company reached on July 6th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.2% to $256.98, Pfizer Inc. rose 1.5% to $26.20, and Gilead Sciences Inc. fell 0.68% to $130.86.

Trading volume totaled 5.5 million, compared to the 50-day average of 7.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 06, 2026 16:35 ET (20:35 GMT)